Similar Papers

Paper Title
Journal
Date
Author
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients
Zheng Zhang ... Ruonan Xu
AIDS | VOL. 27
Zheng Zhang, et. al.Zheng Zhang ... Ruonan Xu
15 May 2013
Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.
Allan K N Alencar ... Marina De M C Da Silva
Frontiers in Pharmacology | VOL. 9
Allan K N Alencar, et. al.Allan K N Alencar ... Marina De M C Da Silva
06 Dec 2018
Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury
Karthick Mayilsamy ... Subhra Mohapatra
Nanomedicine: Nanotechnology, Biology and Medicine | VOL. 29
Karthick Mayilsamy, et. al.Karthick Mayilsamy ... Subhra Mohapatra
26 Jun 2020
What's in a Name?
Arnold I Caplan
Tissue Engineering Part A | VOL. 16
Arnold I CaplanArnold I Caplan
01 Aug 2010
View more papers

More From: Journal of Cardiac Failure

Paper Title
Journal
Date
Author
Balancing fat loss and muscle loss in the quest to reduce obesity in patients with heart failure.
Sheldon E Litwin
Journal of cardiac failure | VOL. -
Sheldon E LitwinSheldon E Litwin
23 Jan 2025
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist Devices: A MOMENTUM 3 Trial Analysis.
Gabriel Sayer ... Nir Uriel
Journal of cardiac failure | VOL. -
Gabriel Sayer, et. al.Gabriel Sayer ... Nir Uriel
22 Jan 2025
Outcomes after Heart Transplantation among Non-Native English-Speaking Recipients.
Fabian Vargas ... Ersilia M Defilippis
Journal of cardiac failure | VOL. -
Fabian Vargas, et. al.Fabian Vargas ... Ersilia M Defilippis
20 Jan 2025
Recovery of Left Ventricular Ejection Fraction in Patients with Anthracycline-Induced Cardiomyopathy- A Contemporary Cohort Study.
Osnat Itzhaki Ben Zadok ... Anju Nohria
Journal of cardiac failure | VOL. -
Osnat Itzhaki Ben Zadok, et. al.Osnat Itzhaki Ben Zadok ... Anju Nohria
20 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.